Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and (Q73869412)
Jump to navigation
Jump to search
scientific article published on 01 June 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and |
scientific article published on 01 June 2000 |
Statements
Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha (English)
Nicoletti F
Di Marco R
Patti F
Zaccone P
L'Episcopo MR
Reggio E
Xiang M
Nicoletti A